Format

Send to

Choose Destination
See comment in PubMed Commons below
Tex Heart Inst J. 2014 Jun 1;41(3):253-61. doi: 10.14503/THIJ-12-2947. eCollection 2014 Jun.

Outpatient management of heart failure in the United States, 2006-2008.

Author information

1
Departments of Internal Medicine (Dr. Mosalpuria) and Cardiology (Dr. Pierre-Louis), Harlem Hospital Center affiliated with Columbia University, New York, New York 10037; Department of Medicine (Drs. Agarwal and Russell), Johns Hopkins University, Baltimore; Maryland 21205; Department of Epidemiology (Dr. Yaemsiri), University of North Carolina, Chapel Hill, North Carolina 27599; and Cardiovascular Institute (Drs. Agarwal, Alvarez, and Saba), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213.

Abstract

Better outpatient management of heart failure might improve outcomes and reduce the number of rehospitalizations. This study describes recent outpatient heart-failure management in the United States. We analyzed data from the National Ambulatory Medical Care Survey of 2006-2008, a multistage random sampling of non-Federal physician offices and hospital outpatient departments. Annually, 1.7% of all outpatient visits were for heart failure (51% females and 77% non-Hispanic whites; mean age, 73 ± 0.5 yr). Typical comorbidities were hypertension (62%), hyperlipidemia (36%), diabetes mellitus (35%), and ischemic heart disease (29%). Body weight and blood pressure were recorded in about 80% of visits, and health education was given in about 40%. The percentage of patients taking β-blockers was 38%; the percentage taking angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARBs) was 32%. Medication usage did not differ significantly by race or sex. In multivariate-adjusted logistic regression models, a visit to a cardiologist, hypertension, heart failure as a primary reason for the visit, and a visit duration longer than 15 minutes were positively associated with ACEI/ARB use; and a visit to a cardiologist, heart failure as a primary reason for the visit, the presence of ischemic heart disease, and visit duration longer than 15 minutes were positively associated with β-blocker use. Chronic obstructive pulmonary disease was negatively associated with β-blocker use. Approximately 1% of heart-failure visits resulted in hospitalization. In outpatient heart-failure management, gaps that might warrant attention include suboptimal health education and low usage rates of medications, specifically ACEI/ARBs and β-blockers.

KEYWORDS:

Ambulatory care/standards; cardiovascular agents/therapeutic use; clinical trials as topic; comprehensive health care; drug utilization/statistics & numerical data; health care surveys; heart failure/drug therapy/economics/epidemiology/prevention & control; office visits/statistics & numerical data/trends/utilization; outcome assessment (health care)/trends; quality assurance, health care

PMID:
24955039
PMCID:
PMC4060338
DOI:
10.14503/THIJ-12-2947
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Allen Press, Inc. Icon for PubMed Central
    Loading ...
    Support Center